GAIN THERAPEUTICS, INC (GANX) Return on equity 2021–2024
GAIN THERAPEUTICS, INC (GANX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-162.3%FY2024 · since FY2021: -224.0% → -162.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -162.3% | -44.3 pp |
| FY2023 | -117.9% | -67.4 pp |
| FY2022 | -50.5% | +173.4 pp |
| FY2021 | -224.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice